Author contributions: L.A.S.A.: conception and design, collection and/or assembly of data, data analysis and interpretation, manuscript writing, and final approval of manuscript; S.A.D. and A.L.S.: conception and design, collection and/or assembly of data, data analysis and interpretation and final approval of manuscript; A.S.A.: collection and/or assembly of data and final approval of manuscript; K.M.M.: conception and design, provision of study material, data interpretation, manuscript writing, and final approval of manuscript; L.A.M.: conception and design, data interpretation, and final approval of manuscript; D.D.W.C.: conception and design, collection and/or assembly of data, data analysis and interpretation, manuscript writing, final approval of manuscript, and financial support; F.M.V.R.: conception and design, data interpretation, manuscript writing, final approval of manuscript, and financial support. S.A.D. and A.L.S. contributed equally to this article.
Disclosure of potential conflicts of interest is found at the end of this article.
First published online in STEM CELLSEXPRESS October 13, 2011.
Expression of the cell surface sialomucin CD34 is common to many adult stem cell types, including muscle satellite cells. However, no clear stem cell or regeneration-related phenotype has ever been reported in mice lacking CD34, and its function on these cells remains poorly understood. Here, we assess the functional role of CD34 on satellite cell-mediated muscle regeneration. We show that Cd34−/− mice, which have no obvious developmental phenotype, display a defect in muscle regeneration when challenged with either acute or chronic muscle injury. This regenerative defect is caused by impaired entry into proliferation and delayed myogenic progression. Consistent with the reported antiadhesive function of CD34, knockout satellite cells also show decreased motility along their host myofiber. Altogether, our results identify a role for CD34 in the poorly understood early steps of satellite cell activation and provide the first evidence that beyond being a stem cell marker, CD34 may play an important function in modulating stem cell activity. STEM Cells 2011;29:2030–2041.
Skeletal muscle exhibits a remarkable capacity to regenerate and completely restore its mass and function rapidly after injury. Upon muscle damage, muscle stem cells, known as satellite cells, exit a normally quiescent state to self-renew and produce myoblasts, which then commit to terminal differentiation and fuse with each other or to existing myofibers to repair damage . Although composing only a small fraction of the nuclei found in adult muscle, satellite cells are the primary source of new myogenic nuclei that contribute to efficient hypertrophy and regeneration, overall having a tremendous capacity to repair damage [2–7].
During regeneration, satellite cells migrate from a necrotic area toward the periphery as well as in the opposite direction, from the viable area to the site of damage [8, 9]. Recently, Siegel et al.  used time-lapse imaging of satellite cells on single fibers to show that satellite cells become extremely motile, crossing the basement membrane to leave their niche as early as 12 hours after culture initiation. Since the initial observation of satellite cell migration , there has been a concerted effort to identify factors that regulate this process. While numerous proteins have been proposed to modulate satellite cell migration [12–16], their specific roles have been difficult to define.
In this study, we focus on the sialomucin CD34. Although it is a marker commonly used to identify and purify satellite cells [17–21], its role in skeletal muscle regeneration remains to be explored. A report by Jankowski et al.  showed that CD34 could be used to separate defined subpopulations of preplated myogenic progenitors, with CD34+ cells having the greatest regenerative capacity. Furthermore, Beauchamp et al.  reported a rapid decrease in CD34 mRNA expression in satellite cells from cultured single fibers early in myogenic progression. Overall, these led us to hypothesize that, as proposed in other cell types [23–28], CD34 could function during activation, initial proliferation, or migration of adult skeletal muscle progenitors.
Here, we describe the regulation of CD34 expression on myogenic cells in vitro and in vivo. Furthermore, we use Cd34-deficient (Cd34−/−) mice to show that CD34 is essential for efficient satellite cell-mediated muscle regeneration in vivo. Our analysis of satellite cells on single fibers and sorted myogenic progenitor cells (MPCs) from Cd34−/− animals reveals a role for CD34 in promoting efficient myogenic progression, specifically in satellite cell migration and entry into cell cycle. Together, our results provide novel insights into the significance and function of CD34 in muscle regeneration as well as in the early steps underlying this complex process.
MATERIALS AND METHODS
Animals were housed in the animal facility of the Biomedical Research Centre in the University of British Columbia (UBC). Mice were kept under sterile conditions, bred in-house, and handled following guidelines approved by the UBC Animal Care Committee. Cd34−/− mice were provided by Dr. Kelly McNagny. Cd34−/− mice were crossed onto the green fluorescent protein (GFP)+CD45.2 background to obtain CD34−/−GFP+CD45.2 mice. LacZ in the Z/AP mice and enhanced GFP expression in the GFP+CD45.2 C56BL/6 mice are both under the control of cytomegalovirus enhancer-chicken β-actin hybrid promoter. These strains were used as wild-type (WT) controls. The Z/AP and GFP+CD45.2 mice were provided by Dr. Corrinne Lobe (MaRS Centre) and Dr. Irving Weissman (Stanford University), respectively. Mdx mice contain a point mutation in the dystrophin gene yielding complete absence of the protein. Myf5/LacZ animals express the β-galactosidase gene under the control of the Myf5 promoter. Both strains were provided by Dr. Michael Rudnicki (Ottawa Health Research Institute). Mice genotypes for CD34−/−, mdx, GFP+, and LacZ+ were determined by polymerase chain reaction (PCR), fluorescence microscopy, or β-galactosidase activity using X-gal.
Acute Muscle Damage
To induce acute damage, 10 μL of notexin (NTX; Latoxan# L8104, 10 μg/mL) was injected in the Tibialis anterior (TA) muscle. WT and Cd34−/− mice were age- (8–9 weeks of age at the time of injection) and sex-matched accordingly. Muscles were harvested at days 5, 7, 10, 14, 21 post-NTX damage, paraffin embedded, and serially sectioned at 5 μm. Slides were H&E stained following standard procedures. Paraffin-embedded tissues were sectioned and stained by Wax-it Histology Services, Inc.
Cross-Sectional Area Measurements
Area measurements were performed using images taken from H&E-stained slides of cross-sectioned muscle. Images were taken with a light microscope (Zeiss Axioplan2 Imaging), and measurements were done on density slices calculated with OpenLab software (version 4.0.4). All measured fibers were verified to ensure that the measurements were done on individual fibers. Regenerating fibers were defined as centrally nucleated fibers (CNFs). Nonregenerating fibers were defined as fibers with peripherally located nuclei.
MPC Preparation, Flow Cytometry Analysis, and Fluorescence-Activated Cell Sorting Isolation
Fluorescence-activated cell sorting (FACS) isolation of myogenic progenitors was performed as previously published . Briefly, primary murine myogenic progenitors were obtained from whole hind limb or TA muscles, carefully harvested from adult mice (6–12 weeks of age), and minced into small pieces. Muscles then underwent enzymatic digestion with 0.2% collagenase type II (Roche# C6885) for 30 minutes followed by collagenase D (Roche# 1088882, 1.5 U/mL) and dispase type II (Roche# 295825, 2.4 U/mL) at 37°C for 1 hour. The homogenized muscle samples were then filtered through a 40-μm cell strainer and the cell suspension was stained with antibodies against CD45, CD31, Sca1, and α7 integrin, along with Hoechst and propidium iodide (PI). All cell surface staining was done on ice. Isotype controls were used to determine gating. Antibodies to CD34 were used when needed. Cells were sorted with BD FACSVantageSE (BD FACSDiva version 188.8.131.52 software). Purity checks were done to ensure sorting efficiency and accuracy. Analyses of samples were performed using FlowJo (version 8.7).
Cytospin and LacZ Stain of Sorted MPCs
Following FACS isolation of MPCs, cells were cytospun at 750 rpm for 5 minutes. Samples were then fixed with 2% paraformaldehyde (PFA) and underwent standard staining for LacZ with X-gal and X-gal staining buffer for detection of β-galactosidase activity.
Quantitative Real-Time and Reverse-Transcription PCR (RT-PCR) Primers
Probes for quantitative PCR (qPCR) analysis of CD34 were purchased from Applied Biosystems (Mm00519283_m1*). RT-PCR primers used to distinguish transcripts for full-length CD34 and truncated CD34 isoforms were 5′-AGCACAGAACTTCCCAGCAA-3′ in exons5/6 and 5′-CCTCCACCATTCTCCGTGTA-3′ in exon8.
Transplantation and Engraftment
Freshly sorted MPCs were obtained from Z/AP+, Cd34−/−GFP+CD45.2, and GFP+CD45.2 adult mice (8–12 weeks of age). A total of 20,000 GFP+ cells from either WT or Cd34−/− animals were mixed with 40,000 LacZ+ cells in PBS. Mixed cells were then injected into the TA muscles of adult WT mice in a 20 μL volume of PBS. Recipient mice were sacrificed 3 weeks post-transplant and perfused with PBS + 10 mM EDTA followed by 4% PFA. Hind limb muscles were harvested and left overnight in 20% sucrose at 4°C. Serial 20-μm sections of optimal cutting temperature TissueTek-embedded muscles were analyzed for engraftment of GFP+ and LacZ+ cells. A ratio was then obtained by taking the maximum number of GFP+ fibers and dividing it by the maximum number of LacZ+ fibers on an adjacent section.
5-Bromo-2′-Deoxyuridine (BrdU) Analysis
Following NTX damage, mice were i.p. injected twice daily with 200 μL BrdU (10 mg/mL) for the first 10 days following muscle damage and once daily after day 10. BrdU (0.8 mgl/mL) was also added to the drinking water. All mice were analyzed on the same day to ensure consistency among samples. Individual TAs were maintained as separate samples. Muscle tissues were processed as per our normal MPC protocol. Permeabilization and denaturation with 0.1% saponin and DNAse (300 μg/mL) treatment were performed followed by addition of anti-BrdU antibody. All data samples were collected by flow cytometry using a BD FACSLSRII machine (BD FACSDiva version 184.108.40.206 software). Analysis of samples was performed using FlowJo (version 8.7). NTX-damaged TAs from mice that did not receive BrdU were used as controls.
Single Fiber Isolations and Confocal Analysis
Single fiber isolations were performed as per standard protocol. Briefly, the extensor digitorum longus (EDL) muscle was gently harvested following sacrifice of the mouse. Collagenase I (Worthington# LS004197, 400 U/mL) digestion for approximately 1 hour in 37°C was performed to obtain single fibers. Fibers were then cultured, harvested, and fixed with 4% PFA at specific time points. Immunofluoresecent staining was done using antibodies to Pax7 (Developmental Studies Hybridoma Bank), MyoD (clone C20, Santa Cruz# sc-304), and CD34 (clone RAM34, eBioscience# 13-0341) diluted in 0.3% TritonX. Analysis was done by confocal microscopy (Nikon C1 laser scanning confocal microscope).
Real-time video imaging and analysis was performed on WT and Cd34−/− single fiber cultures as initially described in the study of Siegel et al. .
Student's two-tailed t test was used on all statistical analyzes performed between groups. Statistical significance was set at p ≤ .05.
CD34 Is Necessary for Efficient Muscle Regeneration in Adult Mice
Cd34−/− mice show no obvious phenotypes under homeostatic conditions [30, 31]. To assess whether CD34 is required for skeletal muscle regeneration, we tested the response of these mice to acute damage induced by NTX injection [32, 33]. Tibialis anterior (TA) muscles from adult WT and Cd34−/− mice were harvested at days 0, 5, 10, 14, and 21 postdamage (Fig. 1A-1J). No differences between WT and Cd34−/− muscle were noticeable prior to damage (Fig. 1A, 1F). At day 5 postdamage, although the size of the damaged areas in the two groups was comparable, a significant increase in the amount of necrotic myofibers was visible in Cd34−/− animals (Fig. 1K). Elevated levels of necrosis can be observed in Cd34−/− animals at all postdamage time points analyzed, indicating a consistent difference in regeneration efficiency between WT and Cd34−/− animals. Furthermore, the appearance of CNFs, characteristic of regenerating myofibers, was delayed in Cd34−/− groups (Fig. 1B vs. 1H) and consistently appeared to be smaller in size (Fig. 1C-1E vs. 1H-1J). Cross-sectional area (CSA) measurements on nondamaged fibers and regenerating CNFs from both WT and Cd34−/− animals confirmed that WT CNFs, but not undamaged fibers, are significantly larger than those from Cd34−/− animals (Fig. 1L, 1M). This suggests that although Cd34−/− animals are capable of initiating repair, their regenerating fibers fail to undergo hypertrophy, a necessary component of muscle regeneration [3, 34].
As the kinetics of satellite cell activation and proliferation may differ between acute and chronic muscle damage, we asked whether the regeneration defect observed in acutely damaged Cd34−/− mice is also present during chronic damage, as for example seen in mdx mice, the murine model for Duchenne muscular dystrophy. Thus, we subjected mdx and mdx/Cd34−/− animals of different ages to the same histological and morphometric analyses. H&E staining shows histological differences reminiscent of those observed after NTX damage (Fig. 1N-1S). In addition, relative to mdx controls, CSA measurements showed a significant decrease in regenerating myofiber sizes of mdx/Cd34−/− animals at 4 weeks of age, a time when the first wave of myodegeneration takes place, and at 6 months of age. Interestingly, when 18-month old mice were analyzed, no significant differences were observed between the two groups (Fig. 1T). Together, our data from acute and chronic damage models support a key role for CD34 in ensuring efficient muscle repair.
Prospective Isolation of Adult Skeletal MPCs and Characterization of CD34 Expression
FACS can be used to prospectively isolate myogenic progenitors from adult mice [19, 20, 29, 35, 36]. Thus, we used FACS to explore the expression of CD34 on purified myogenic progenitors, isolated as Hoechst+, PI−, CD45−, CD31−, Sca1−, α7 integrin+ cells, hereafter referred to as MPCs (Supporting Information Fig. S1A). This population contains all myogenic activity found in adult skeletal muscle [21, 29].
As CD34 expression has been reported on most, but not all, myogenic cells, we assessed the myogenic potential of the CD34+ and CD34− MPC fractions. MPCs isolated from Myf5LacZ mice, which express β-galactosidase in satellite cells under the control of the Myf5 promoter , showed β-galactosidase activity only in the CD34+ fraction (Fig. 2B, 2C). Furthermore, limiting dilution assays showed that the frequency of cells capable of initiating colonies containing multinucleated, myosin heavy chain (MyHC) positive, myotubes is negligible within the CD34− fraction (1 in 31 cells in CD34+ fraction vs. 1 in 2,921 cells in CD34− fraction). In summary, our results show that essentially all myogenic activity in sorted MPCs is contained within the CD34+ subset.
CD34 expression on myofiber-associated satellite cells is extinguished shortly after the isolated fibers are placed in culture . As the conditions used in these cultures promote satellite cells expansion, likely by mimicking the environment of damaged muscle, we hypothesized that a similar downregulation may be observed following damage in vivo. Indeed, FACS analysis revealed that CD34 is downregulated from the surface of MPCs starting at day 3 postdamage and is essentially absent by day 5. At day 10, a time that follows the cessation of their proliferation , MPCs begin to re-express CD34 on their surface and by day 21, CD34 surface expression is fully restored (Fig. 2C). Real-time qPCR (qRT-PCR) analysis of sorted MPCs confirmed the downregulation of total CD34 mRNA soon after damage (Fig. 2D). In contrast, the expression of CD34 on Sca1+ α7 integrin− fibro-adipogenic progenitors (FAPs) remains constant throughout the time course (data not shown), despite the fact that FAPs proliferate to the same extent as myogenic cells , indicating that CD34 regulation is specific to MPCs.
Additionally, we assessed whether CD34 regulation also occurs at the level of isoform expression. Two different isoforms of CD34 have been described, a full-length (CD34FL) and a truncated version (CD34CT), which lacks most of the cytoplasmic domain . A switch in expression from CD34CT to CD34FL has been reported on cultured satellite cells . Using endpoint RT-PCR, our investigation of CD34 isoform expression in vivo shows that in nondamaged muscle, MPCs exclusively express CD34FL. On satellite cell activation and proliferation (days 1–5 post-NTX damage), both CD34FL and CD34CT are coexpressed. By day 7, when regeneration is well underway, the CD34FL again becomes the predominant isoform (Fig. 2E). As CD34FL and CD34CT are distinct in their ability to interact with cytoplasmic proteins [39, 40], a change in isoform expression may lead to changes in CD34 localization. However, confocal analysis of CD34 localization on Pax7+ satellite cells associated to cultured single fibers from the EDL muscle failed to reveal any obvious changes beyond surface down-regulation (Fig. 2F-2Q).
Our analysis confirms that CD34 expression is rapidly downregulated on satellite cells following damage. This tight regulation, together with the observed muscle regeneration defect in Cd34−/− mice, provides support to the notion that CD34 plays a fundamental role in the myoregenerative process. As CD34 is no longer expressed in MPCs entering differentiation, such role is likely to be in satellite cell activation, migration, or proliferation.
Defective Engraftment of Cd34−/− MPCs
Many CD34+ cell types [29, 38, 41, 42] have been proposed to participate in muscle regeneration. To test whether the observed muscle regeneration defect in Cd34−/− animals reflects a direct effect of CD34 loss in MPCs, we functionally compared WT and Cd34−/− MPCs. We began by testing their ability to differentiate in vitro. Sorted cells were expanded under growth conditions for 5 days and then exposed to differentiation conditions for 5 days. Multinucleated, MyHC+ myotubes were readily observed in both WT and Cd34−/− samples (Fig. 3A). Fusion index calculations, a standard measure of differentiation efficiency, confirmed that Cd34−/− MPCs differentiate in vitro as efficiently as WT (Fig. 3B). These results are consistent with the observation that CD34 disappears from the cell surface prior to the appearance of mature myofibers, suggesting that it would have little impact on the ability of MPCs to differentiate.
Nevertheless, because in vitro differentiation conditions may not faithfully recapitulate the in vivo environment , we further tested the myogenic potential Cd34−/− MPCs in vivo using cell transplantation. MPCs were freshly sorted from three groups of mice: (1) Z/AP mice ubiquitously expressing LacZ, (2) WT mice ubiquitously expressing GFP (WT/GFP+), and (3) GFP+ mice lacking CD34 (Cd34−/−/GFP+). LacZ+ MPCs, initially used as internal standards, were mixed with either WT/GFP+ or Cd34−/−/GFP+ MPCs prior to transplantation into nondamaged TA muscles of WT recipients. Engraftment was assessed 3 weeks later by quantifying donor-derived, GFP+ myofibers (Fig. 3C). Comparable numbers of LacZ+ fibers were observed in all samples (Fig. 3D and Supporting Information Fig. S2A), confirming that no bias was introduced prior to injection. In support of a cell autonomous role of CD34 in MPCs, our results reveal that Cd34−/−/GFP+ MPCs engraft with significantly decreased efficiency compared to WT/GFP+ MPCs (Fig. 3E, 3F and Supporting Information Fig. S2B).
To exclude a difference in the frequency of myogenic cells contained within WT and Cd34−/− MPCs as the cause for our observation, we sorted MPCs from WT and Cd34−/− mice carrying a Myf5LacZ transgene. No significant difference in the number of β-galactosidase+ cells, indicative of MPC frequency, was noted between the two groups (Fig. 3G, 3H, and Supporting Information Fig. S2C). Overall, these data demonstrate that CD34 expression on MPCs is required for the efficient generation of myofibers following transplant and suggest that the muscle regeneration defect seen in Cd34−/− mice can be attributed to a cell autonomous defect of MPCs.
Loss of CD34 on MPCs Leads to Impaired Proliferation In Vivo Following Acute Damage
Recent publications suggest that a burst of proliferation occurs following transplant of MPCs to recipient muscle [19, 44]. As WT and Cd34−/− MPCs are equally able to generate myotubes in vitro (Fig. 3A, 3B), we hypothesized that inefficient proliferation of Cd34−/− MPCs may underlie the phenotype observed in Cd34−/− mice. To assess MPC proliferation in vivo, mice were treated with BrdU and injected with NTX. FACS analysis show significantly decreased BrdU incorporation in Cd34−/− MPCs 3 days postdamage, when WT MPCs proliferation is maximal (Fig. 4A, 4B). A similar trend of inefficient Cd34−/− MPC proliferation is observed at day 5. This proliferation defect is not observed in FAPs, providing further evidence that CD34 plays a selective role in MPC function (Fig. 4C).
The lower frequency of BrdU+ MPCs could reflect either a reduction in their proliferative response or the selective loss of Cd34−/− cells. To distinguish between these possibilities, we used terminal deoxynucleotidyl transferase dUTP nick end labeling staining of WT and Cd34−/− muscle sections to detect apoptotic cells 3 days postdamage. We observed little to no apoptosis in either groups (data not shown), indicating that the decreased amount of Cd34−/− MPCs is not due to increased apoptosis. Thus, our results suggest that CD34 is required for the efficient expansion of MPCs after muscle injury in vivo.
CD34 Is Necessary for the Efficient Entry of Satellite Cells into Proliferation
One potential explanation for the observed reduction in proliferating MPCs could be delayed satellite cell entry into proliferation. To test this hypothesis, we cultured fibers from adult EDL muscles of WT and Cd34−/− animals. No difference in numbers of Pax7+ satellite cells was apparent immediately after fiber isolation (Fig. 5A), indicating that CD34 is dispensable for the maintenance of satellite cell numbers during homeostasis.
We then examined the progression of satellite cells through the myogenic program by assessing Pax7 and MyoD expression. Pax7 is highly expressed in quiescent satellite cells; but, on entry into cycle, these cells initiate expression of MyoD and eventually downregulate Pax7 as they commit to differentiation [45, 46]. Thus, two myogenic progenitor populations can then be identified: activated satellite cells (Pax7+ MyoD+) and differentiation-committed myoblasts (Pax7− MyoD+) (Fig. 5B). Analyses of these populations over time in WT and Cd34−/− single fiber cultures revealed no significant difference in the frequency of Pax7+ cells that activate MyoD expression. However, analysis of the differentiation-committed myoblast population shows that while these cells become evident in WT samples, they are absent in Cd34−/− fibers after 48 hours of culture. At the 72-hour time point, although differentiation-committed myoblasts are now readily detectable on Cd34−/− fibers, their frequency remains significantly lower than on WT fibers (Fig. 5C). Thus, the lack of CD34 on satellite cells results in a significant delay in their progression along the myogenic program.
We next examined whether their proliferation is also similarly delayed. On WT fibers, an increase in the total number of myogenic cells, defined as cells expressing Pax7 and/or MyoD, is clearly observed at 48 hours following culture initiation. In contrast, no such increase is detected on Cd34−/− fibers until 72 hours following culture. At this point, WT fibers harbor significantly more myogenic cells than Cd34−/− fibers (Fig. 5D). Because these differences were not present initially, they reveal a striking reduction in the ability of Cd34−/− satellite cells to expand. Cd34−/− myogenic progenitors do proliferate, as can be seen by their sharp increase between 48 and 72 hours in culture. However, this proliferation is delayed when compared to WT fibers, whose associated myogenic progenitor numbers begin to increase between 24 and 48 hours in culture (Fig. 5D). In addition, the in vitro doubling time of Cd34−/− myogenic progenitors was considerably longer than that of WT cells (45.31 hours vs. 30.81 hours, respectively), providing further evidence that the lack of CD34 on myogenic progenitors indeed results in reduced proliferation.
To further confirm these results, we performed time-lapse imaging of cultured single fibers , which allows us to directly monitor satellite cell divisions. We observed fewer divisions on Cd34−/− fibers between 24 and 48 hours of culture compared to WT controls (Fig. 5E), reflecting a smaller percentage of Cd34−/− cells entering the cell cycle (44.2% vs. 20.6%). Furthermore, the first division of Cd34−/− satellite cells was significantly delayed (Fig. 5F). Altogether, these data argue that CD34 is essential for satellite cells to efficiently enter their first cell cycle. Subsequently, the lack of CD34 results in reduced expansion of myogenic cells as well as delayed progression through the myogenic program.
CD34 Is Essential for Efficient Satellite Cell Motility
CD34 has been proposed to promote the efficient migration of hematopoetic cells through its antiadhesive functions [23, 39, 40]. Since Siegel et al.  have established that satellite cells undergo extensive movement and migratory behavior during culture, we evaluated the motility of Cd34−/− satellite cells on their native substrate, the myofiber.
Live imaging of WT and Cd34−/− single fibers was initiated 24 hours after isolation and continued for an additional 24 hours . During this period, both WT and Cd34−/− cells were found to be actively motile, but WT cells exhibited substantially more movement than Cd34−/− cells (Supporting Information videos S1, S2). Direct tracking of individual satellite cells over time revealed a dramatic reduction in average speed and overall distance traveled by Cd34−/− cells in comparison to WT controls (Fig. 6A-6C). Evaluation of the instantaneous velocities show that WT cells move faster throughout this period, suggesting that the decreased motility of Cd34−/− cells is not due to a delay in initiating movement but rather to a defect in migration (Fig. 6D). Overall, these data support a key role for CD34 in promoting efficient satellite cell movement.
One of the earliest motility-associated phenomena that take place during satellite cell activation is their exit from the niche. To test whether this process is also delayed in Cd34−/− animals, the position of individual Pax7+ satellite cells on cultured fibers relative to the laminin+ basement membrane was assessed by confocal microscopy. We observed no difference in the proportion of WT and Cd34−/− cells located above or below the basement membrane, indicating that the inefficient motility of Cd34−/− satellite cells does not affect their ability to exit from the niche (Supporting Information Fig. S3A).
CD34 is a well-known surface marker used to isolate various progenitor cells, yet is also notorious for leaving researchers questioning its exact functional role. Previous reports speculated that CD34 may function as a homing receptor, a blocker of differentiation, a proadhesive receptor, or, conversely, an antiadhesion molecule . Efforts to directly reveal a function for CD34 have been hampered by the fact that CD34 is one member of a functionally redundant family of three sialomucins (CD34, podocalyxin, and endoglycan) with an overlapping tissue distribution [40, 47, 48]. This may, in part, explain why Cd34−/− mice show no obvious defects in tissues where its homologues are expressed. Recent studies, however, showed that phenotypes in these mice can be revealed when a specific system is challenged, thus leading to more precise hypotheses of CD34's function [23, 49–51].
In this study, we evaluated muscle regeneration in adult Cd34−/− animals and observed a clear impairment in both acute and chronic damage models. Notably, in the chronic damage model, this defect was no longer apparent in aged, 18-month-old animals. However, as impaired regeneration in mdx mice has been attributed to satellite cell exhaustion [52, 53], the defects in satellite cell function caused by the lack of CD34 could be masked in aged animals.
A detailed analysis of CD34 expression on normal MPCs at steady state and during regeneration following acute damage showed that, consistent with previous results in vitro, CD34 expression is regulated during in vivo regeneration and is downregulated prior to differentiation. However, on analysis of CD34 isoform expression, we find our results from sorted MPCs in apparent contradiction with those published using individual satellite cells from single fibers , despite our use of the same primers on multiple experiments. One possible explanation for this discrepancy could be that some of the cells assayed in the study of Beauchamp et al. may have been FAPs, which can contaminate fiber preparations . Nevertheless, in support for our hypothesis that CD34's role is likely in the early stages of myogenesis, our results show that it is during the stages prior to differentiation, when CD34 is regulated, that defects are observed in Cd34−/− myogenic cells. The defective engraftment of Cd34−/− MPCs in WT recipients conclusively supports the notion that CD34 plays a cell autonomous role in MPCs.
More specifically, our data demonstrates that CD34 is required for MPCs and satellite cells to proceed through the early stages of myogenic progression, defined here as the period spanning from the onset of damage to the first satellite cell division. Three main events take place during this time. (1) Satellite cells exit the niche by crossing the basement membrane. Presumably, this requires the cells to be motile; however, no defect in this first step was observed in Cd34−/− fiber cultures, suggesting the effect of CD34 on motility is not generalized. (2) Satellite cells move rapidly at relatively large distances. In vitro, this movement takes place on the outside surface of the basement membrane ensheathing the myofibers, which likely represents the interstitial space in regenerating tissue in vivo. (3) Myogenic cells begin to proliferate. We have found that these latter two processes, movement and proliferation, are clearly defective in Cd34−/− myogenic progenitors.
The relationship between satellite cell movement and proliferation remains debatable. Some published work suggests that movement follows division , while our data demonstrates that satellite cells can become motile before dividing (Supporting Information videos S1, S2). However, it has been shown that proliferation can proceed despite blocked movement . Evidence that both proliferation and motility are affected in Cd34−/− mice suggests that a functional link between the two may exist. But, it is also possible that CD34 plays independent roles in each of these processes. Interestingly, links between CD34 and both proliferation and motility have been independently established in other systems. Cd34−/− mast cells and eosinophils display defective inflammatory migration, an effect that has been ascribed to the loss of CD34 antiadhesive properties [23, 39]. In support of a role for CD34 in facilitating the entry of quiescent cells into proliferation, Trempus et al.  reported that Cd34−/− animals failed to develop papillomas upon 7,12-dimethyl-benz[a]anthracene/phorbol ester 12-O-tetradecanoylphorbol-13 acetate induction, a phenomenon attributed to inefficient hair follicle stem cell activation. Finally, studies comparing CD34+ and CD34− hematopoietic stem cell subsets show a higher percentage of proliferating cells in the CD34+ population  providing a link between CD34 and proliferation. Our data lend further support to this concept as we find a clear role for CD34 in mediating activation, proliferation, and motility of myogenic cells.
Although the reported antiadhesive properties of CD34 are likely to be at the basis for its function in promoting cell motility, the molecular link between this molecule and proliferation is still unresolved. Interestingly, another sialomucin, CD164, has been described to regulate myoblast motility and fusion through modulation of satellite cell responses to the chemokine stromal cell–derived factor 1 (SDF-1) . Moreover, it has been shown that CD34+ myogenic cells express higher levels of the SDF-1 receptor, C-X-C chemokine receptor 4 (CXCR4), compared to the CD34− population , suggesting a role for CD34 in CXCR4 signaling. However, we failed to detect any change in the ability of Cd34−/− cells to migrate in response to SDF-1 (data not shown), suggesting that CD34 acts through other mechanisms, the elucidation of which requires further investigation.
In summary, we have shown that CD34 is necessary for efficient muscle regeneration in response to both acute and chronic damage. The downregulation of both mRNA and surface protein levels of CD34 expression on myogenic precursors shortly following damage in combination with the defective engraftment of Cd34−/− MPCs indicates that CD34 plays a cell autonomous role on myogenic progenitors during the early phase of adult myogenesis. Our data demonstrating impaired motility and delayed entry into proliferation of Cd34−/− satellite cells further support this notion. Overall, we show that CD34 is not just a useful marker of MPCs, but it is required for efficient myogenic progression.
We thank L. Yi, J. Duenas, J. Kang, S. Boumahdi, A. Johnson, J. Wong, the BRC animal facility and BRC Core Staff for their expert technical assistance; Dr. B. Ajami, Dr. G. Alfaro, B. Paylor, and Dr. M. Long for help in editing the manuscript. This research was supported by grants from CIHR (MOP-82864) to F.M.V.R; D.D.W.C is supported by the National Institute of Health (NIH, 1R21AR056814-01); and K.M.M. is supported by CIHR (MOP-84545) and is a Michael Smith Foundation for Health Research Senior Scholar. L.A.S.A was supported by fellowships from the Natural Sciences and Engineering Research Council of Canada (NSERC, PGSD2-362406-2008) and the Michael Smith Foundation for Health Research (MSFHR, ST-JGS-062(06-1)BM).
DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST
The authors indicate no potential conflicts of interest.